Stocks
Novo Nordisk (NVO) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF | ? | 47 615 000 000 | 64 134 000 000 | 70 012 000 000 | 69 659 000 000 | 28 989 000 000 | 31 029 000 000 | ||
| Changes by years, y/y, % | +59% | +35% | +9% | -1% | -58% | -0.6% | |||
Novo Nordisk. FCF
Novo Nordisk. FCF, changes, %
Novo Nordisk. FCF, sum by quarters
Novo Nordisk (NVO) FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF | ? | 10 005 000 000 | 24 510 000 000 | 30 692 000 000 | -36 218 000 000 | 12 045 000 000 | 31 029 000 000 | |
| Changes by years, y/y, % | +89% | -34% | -2% | +751% | +20% | |||
| Changes by quarters, q/q, % | -335% | +145% | +25% | -218% | -133% | |||
